2025 annual financial data
Ligand Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was 17.61%.
Operating income was 47,199,000 USD and net income was 124,453,000 USD.
Operating cash flow was 49,359,000 USD.
Get free Ligand Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 268,087,000 USD
- Operating income
- 47,199,000 USD
- Net income
- 124,453,000 USD
- Operating cash flow
- 49,359,000 USD